Transparent or Traditional

Ascend’s Compound Strategy drives greater control of rising compound costs and utilization trends while addressing key safety, efficacy and quality risks associated with current compounding practices. As a part of our core services, we offer a two-fold strategy to manage compounds - exclusion and PA with $300 threshold – and help address the current and future compound drug issues. Designed to target both high-cost individual ingredients within compounds, as well as high-cost compound prescriptions, we continue to provide access for members when commercially available products are either not available at all, or not available in a dosage form that meets the need of the patient. This optional program is an optimal balance of safety, cost-efficiency, quality and accessibility of compound medications.

ARE YOU READY TO DISCUSS YOUR BENEFIT PLAN WITH AN EXPERT?